Google Alert - hepatitis c

[Guest guest]

Google News Alert for: hepatitis c

Rivals abound for Ga. congressman with hepatitis CMacon TelegraphJust a few months after revealing he suffers from hepatitis C, US Rep. Hank suddenly faces a crowded field of rivals as he seeks a third term in ...See all stories on this topic

Hepatitis C for FoolsMotley Fool (blog)I'm hoping to eventually find the time to describe the hepatitis C programs of about ten developmental biotechs as well as a few competing compounds from ...See all stories on this topic

CBC.caHep C sufferers endangering health to get treatmentCBC.caBy Kathy Tomlinson, CBC News Health-care workers who treat hepatitis C are raising the alarm about patients who are binge drinking and taking dangerous ...See all stories on this topic

Dialysis patients 'contract hep C'Shanghai DailyBy Echo Wang | 2010-3-4 | NEWSPAPER EDITION ABOUT 30 kidney patients in Jiangsu Province allegedly contracted hepatitis C during dialysis treatments, ...See all stories on this topic

Abbott And Enanta Announce Advancement Of Hepatitis C CollaborationMedical News Today (press release)Abbott (NYSE: ABT) and Enanta Pharmaceuticals announced the advancement of their Hepatitis C (HCV) collaboration into Phase 2 clinical trials. ...See all stories on this topic

There's More to Hepatitis Than HCVAbout.com: HealthThere's more to hepatitis than hepatitis C. To many people, it's not worth the time to sort out the ABCs of hepatitis soup: if you have hepatitis then you ...See all stories on this topic

Abbott, GSK to Develop PCR-Based Molecular Dx to Select Patients for Trial ...GenomeWeb Daily NewsOutside the US, Abbott offers an extensive menu of infectious disease tests on the system, including for HIV-1 viral load, hepatitis B and C viral load, ...See all stories on this topic

Another Options Play for a Volatile BiotechTheStreet.com (subscription)Intermune is a bit different than Medivation and Xenoport in that it also has another promising drug for hepatitis C. Also, the data for phase III results ...See all stories on this topic

Enanta Nominates EDP-239 as Lead Development Candidate for NS5A HCV Inhibitor ...PharmaLive (press release) (subscription)Hepatitis C is a liver disease affecting over 170 million people worldwide. The virus is spread through direct contact with the blood of an infected person. ...See all stories on this topic

Human Genome Sciences reports net income of $5.7 million for 2009Washington Post"Benlysta is going to drive the growth going forward," he said. By contrast, the hepatitis C drug is "not revolutionary, it's evolutionary," he said.See all stories on this topic